BioVie Inc

10/17/2023

Did you know? Alzheimer’s disease (AD) is one form of dementia, and it is believed to be a neuroinflammatory, neurodegenerative condition, characterized by progressive deterioration of short-term memory and problem-solving ability. 🧠💡

10/09/2023

Join us in raising awareness for . Together, we can:

🔬 Support research for early detection & treatment.
🤝 Provide care and support to affected individuals and families.
🧠 Promote brain health through lifestyle choices.
Let's unite to make a difference!

10/04/2023

🧠 Alzheimer's disease, is a complex neurodegenerative condition, that demands everyone's attention. Let's prioritize research, innovative therapies, and early detection methods to unlock the mysteries of this debilitating disorder. 📚🔬

10/03/2023

Every day, we're pushing the boundaries of science and innovation to bring hope, healing, and brighter tomorrows to those affected by this challenging condition. Together, we can make a difference in the Alzheimer's space and change lives for the better. 💪💙

09/28/2023

Our dedicated team is tirelessly working to make a difference in the lives of those battling . 🤝 Together, we're pioneering innovative treatments for a brighter, symptom-free future. 💪

09/12/2023

https://youtu.be/5zBo5cUhbzI

BioVie Inc continues to release compelling research regarding Parkinson's and Alzheimer's disease treatment. New research was just presented at the International Parkinson and Movement Disorder Society (MDS) 2023 International Congress of Parkinson’s Disease and Movement Disorder.

Jane King interviews Cuong Do, CEO, BioVie. (NASDAQ: BIVI) https://bioviepharma.comInnovators with Jane King profiles tech companies and thought leaders in t...

09/12/2023

🔬 Making Progress Together! 🌟

At BioVie, we're committed to advancing healthcare and improving lives. Our team is dedicated to researching innovative solutions for Parkinson's Disease and beyond.